Journal of Pharmacology and Experimental Therapeutics: 381 (3)

June 01, 2022; Volume 381,Issue 3

Cardiovascular

You have access
L-Arginine Enhances the Effects of Cardiac Rehabilitation on Physical Performance: New Insights for Managing Cardiovascular Patients During the COVID-19 Pandemic
Pasquale Mone, Raffaele Izzo, Giuseppe Marazzi, Maria Virginia Manzi, Paola Gallo, Giuseppe Campolongo, Luca Cacciotti, Domenico Tartaglia, Giuseppe Caminiti, Fahimeh Varzideh, Gaetano Santulli and Valentina Trimarco

Journal of Pharmacology and Experimental Therapeutics June 2022, 381 (3) 197-203; DOI: https://doi.org/10.1124/jpet.122.001149
You have access
Neutrophil-Derived Myeloperoxidase and Hypochlorous Acid Critically Contribute to 20-Hydroxyeicosatetraenoic Acid Increases that Drive Postischemic Angiogenesis
Juan A. Azcona, Samantha Tang, Elizabeth Berry, Frank F. Zhang, Radha Garvey, John R. Falck, Michal Laniado Schwartzman, Tao Yi, Thomas M. Jeitner and Austin M. Guo

Journal of Pharmacology and Experimental Therapeutics June 2022, 381 (3) 204-216; DOI: https://doi.org/10.1124/jpet.121.001036
You have access
Cardiac Anthracycline Accumulation and B-Type Natriuretic Peptide to Define Risk and Predictors of Cancer Treatment–Related Early Diastolic Dysfunction
Giorgio Minotti, Emanuela Salvatorelli, Giorgio Reggiardo, Fabio Mangiacapra, Massimiliano Camilli and Pierantonio Menna

Journal of Pharmacology and Experimental Therapeutics June 2022, 381 (3) 266-273; DOI: https://doi.org/10.1124/jpet.122.001101

You have access
Angiotensin-Converting Enzyme 2 Inhibits Lipopolysaccharide-Caused Lung Fibrosis via Downregulating the Transforming Growth Factor β-1/Smad2/Smad3 Pathway
Xingsheng Lin, Wenhao Lin, Yingfeng Zhuang and Fengying Gao

Journal of Pharmacology and Experimental Therapeutics June 2022, 381 (3) 236-246; DOI: https://doi.org/10.1124/jpet.121.000907
You have access
Anisodamine Enhances Macrophage M2 Polarization through Suppressing G9a-Mediated Interferon Regulatory Factor 4 Silencing to Alleviate Lipopolysaccharide-Induced Acute Lung Injury
Yunfeng Zhang, Dingli Song, Ziyang Peng, Rui Wang, Kai Li, Hong Ren, Xin Sun, Ning Du and Shou-Ching Tang

Journal of Pharmacology and Experimental Therapeutics June 2022, 381 (3) 247-256; DOI: https://doi.org/10.1124/jpet.121.001019

You have access
Central Nervous System Delivery of the Catalytic Subunit of DNA-Dependent Protein Kinase Inhibitor Peposertib as Radiosensitizer for Brain Metastases
Surabhi Talele, Wenjuan Zhang, Ju-Hee Oh, Danielle M. Burgenske, Ann C. Mladek, Sonja Dragojevic, Jann N. Sarkaria and William F. Elmquist

Journal of Pharmacology and Experimental Therapeutics June 2022, 381 (3) 217-228; DOI: https://doi.org/10.1124/jpet.121.001069

You have access
Ligustrazine Attenuates Liver Fibrosis by Targeting miR-145 Mediated Transforming Growth Factor-β/Smad Signaling in an Animal Model of Biliary Atresia
Jian-Li Qiu, Guo-Feng Zhang, Yu-Na Chai, Xiao-Yan Han, Hai-Tao Zheng, Xiang-Feng Li, Fei Duan and Ling-Yan Chen

Journal of Pharmacology and Experimental Therapeutics June 2022, 381 (3) 257-265; DOI: https://doi.org/10.1124/jpet.121.001020

You have access
Anesthetic Preconditioning of Traumatic Brain Injury Is Ineffective in a Drosophila Model of Obesity
Dena Johnson-Schlitz, Julie A. Fischer, Hannah J. Schiffman, Amanda R. Scharenbrock, Zachariah P.G. Olufs, David A. Wassarman and Misha Perouansky

Journal of Pharmacology and Experimental Therapeutics June 2022, 381 (3) 229-235; DOI: https://doi.org/10.1124/jpet.121.000997

You have access
Correction to “The Skeletal Muscle Relaxer Cyclobenzaprine Is a Potent Non-Competitive Antagonist of Histamine H1 Receptors”
Journal of Pharmacology and Experimental Therapeutics June 2022, 381 (3) 274; DOI: https://doi.org/10.1124/jpet.121.000998err